Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs CRL✓SelectedUSD · CRLGSK vs CRL performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs CRL

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+7.3%
CRL return
+93.0%
Excess return
-85.7%
Maximum drawdown
-22.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioCRLExcessAlpha
1D-0.1%-4.2%+4.0%+0.1%
7D-5.3%-7.0%+1.7%-5.0%
30D-3.7%-8.9%+5.2%-3.4%
3M-7.3%+7.8%-15.1%-8.3%
6M-4.2%+101.4%-105.7%-9.6%
YTD+0.9%+57.6%-56.7%-5.6%
1Y+7.3%+93.9%-86.7%-7.6%
All+7.3%+93.0%-85.7%-7.6%

Cumulative growth

Daily Returns

Daily percentage return beside CRL.

Daily Out/Under-Performance

Portfolio return minus CRL return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CRL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded CRL wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling